In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

D. Medical Industries, Ltd.

http://dmedicalindustries.com/

Latest From D. Medical Industries, Ltd.

Sales Grow Across C&D's Products And Regions, But Increasing Supply Costs Stunt Income

Raw material supplies slowed during January-March period by catastrophic freeze in Texas and shortage of shipping containers partly due to Suez Canal blockage. "We're absorbing $90 million of incremental costs for the full year,” says CFO Ronald Dierker.

Dietary Supplements Sales & Earnings

No Pandemic Hangover Expected For Health, Beauty Launches At Independent Pharmacies

Wellness products accounted for the highest number of launches among health, wellness and beauty products at independent pharmacies in 2020. But the overall number slumped 21.1% due to the pandemic, according to Hamacher Resource Group’s report on a product rating system.

Market Intelligence Launches

Church & Dwight Lifts Curtain On 2021: Halle Berry For Flawless, Vitafusion In Cough/Cold Aisle

Emerging markets expected to be growth drivers across C&D’s supplement, OTC drug and household care product lines in 2021. Super Immune formulation with more than 100% daily value of vitamin C, zinc and elderberry and Manuka honey is first vitafusion product in cough/cold aisle and brand's first extension for 2021.

Sales & Earnings Consumer

Church & Dwight Takes Homeopathic Turn For OTC Sales Driver, Acquires Zicam Marketer Matrixx

C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.

M & A OTC Drugs
See All

Company Information

  • Industry
  • Biotechnology
  • Miscellaneous
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
  • In Vitro Diagnostics
    • Glucose Testing
  • Other Names / Subsidiaries
    • D-Medical
UsernamePublicRestriction

Register